View Older Stories

Mar 26, 2026 08:30AM Tivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation Syndrome

Mar 25, 2026 04:05PM Tivic Reports Full Year 2025 Results

Mar 24, 2026 09:32AM Tivic Health shifts focus to biopharmaceuticals, discontinues device sales

Mar 24, 2026 09:30AM Tivic Health CEO Letter to Shareholders

Mar 20, 2026 03:35PM Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET

Mar 4, 2026 08:30AM Biotech Veteran Michael K. Handley Named CEO of Tivic Health Systems to Spearhead Strategic Expansion in Biopharma

Feb 18, 2026 09:29AM Tivic schedules follow-up meeting with BARDA on radiation drug

Feb 18, 2026 09:15AM Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10

Jan 28, 2026 08:30AM Tivic, BARDA Discuss Entolimod(TM) for Acute Radiation Syndrome at TechWatch Meeting

Jan 26, 2026 10:10AM Tivic to Showcase Strategic Pivot and Forward Outlook on Advancing Entolimod(TM) to Commercialization at DealFlow Discovery Conference

Jan 23, 2026 02:50PM DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event

Jan 23, 2026 02:50PM DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event

Jan 23, 2026 02:50PM DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event

Jan 23, 2026 02:50PM DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event

Jan 20, 2026 05:50PM Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual Conference

Jan 12, 2026 09:00AM Tivic scales up Entolimod manufacturing by 200x for radiation syndrome drug

Jan 12, 2026 09:00AM Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity

Jan 8, 2026 08:30AM Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines

Dec 29, 2025 05:09PM Tivic Health Systems (TIVC) files for 13.7M share offering by selling stockholders

Dec 29, 2025 05:08PM Tivic Health Systems (TIVC) files for 36.14M share offering by selling stockholders

Dec 11, 2025 09:46AM Tivic acquires manufacturing assets, launches subsidiary with $90M financing

Dec 11, 2025 09:45AM Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing Package

Nov 18, 2025 08:30AM Tivic Secures Barda Meeting for Entolimod(TM) for Acute Radiation Syndrome

Nov 14, 2025 05:50PM Tivic Health Systems (TIVC) Misses Q3 EPS by 197c

Nov 14, 2025 04:30PM Tivic Reports Third Quarter 2025 Financial Results

Nov 13, 2025 08:32AM Tivic Health optimizes cervical vagus nerve stimulation parameters

Nov 13, 2025 08:30AM Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS)

Nov 10, 2025 09:02AM Tivic files two new patent applications to expand IP portfolio

Aug 20, 2025 08:30AM Tivic receives two drug applications for Entolimod cancer treatment

Aug 15, 2025 08:47AM Tivic Health meets with government agencies on radiation drug development

Aug 14, 2025 04:47PM Tivic Health Systems (TIVC) Misses Q2 EPS by 219c

Jul 8, 2025 08:34AM Tivic Health shareholders approve equity proposals for drug licensing deals

May 15, 2025 05:56PM Tivic Health Systems (TIVC) Misses Q1 EPS by 252c

May 14, 2025 08:31AM Tivic Health Systems (TIVC) enters GMP manufacturing agreement with Scorpius Bio

Apr 22, 2025 08:33AM Tivic Health Systems (TIVC) Reports White House Briefing and FDA Meetings Secured Positive Interest in Potential Military and Defense Applications of Its Product Candidates

Apr 10, 2025 08:33AM Tivic Health Systems (TIVC) Regains Nasdaq Compliance

Mar 6, 2025 08:16AM Tivic Health Systems (TIVC) and Feinstein Institute Present New Data Showing Personalized Vagus Nerve Stimulation Method Optimizes Impact on Autonomic Nervous System

Mar 5, 2025 08:15AM Tivic Health Systems (TIVC) Announces Reverse Stock Split

Mar 3, 2025 08:15AM Tivic Health Systems (TIVC) Files Patent For Optimized Electrical Stimulation of the Vagus Nerve

Feb 12, 2025 08:32AM Tivic Health Systems (TIVC) acquires rights to Entolimod from Statera Biopharma

Dec 23, 2024 04:55PM Tivic Health Systems (TIVC) CEO Issues Letter to Shareholders

Sep 18, 2024 09:00AM Tivic Health Systems (TIVC) Receives Approval from Institutional Review Board for ncVNS Optimization Study, Readies for Enrollment

Sep 17, 2024 09:02AM Tivic Health Systems (TIVC) Accelerates VNS Commercial Strategy Development

Aug 14, 2024 05:10PM Tivic Health Systems (TIVC) Misses Q2 EPS by 32c

Jul 23, 2024 10:08AM Tivic Health Systems (TIVC) Expands Intellectual Property Portfolio

Jun 18, 2024 09:15AM Tivic Health Systems (TIVC) Appoints Christina Valauri to its Board

View Older Stories